Interferon (IFN) production following exposure to Epstein-Barr virus (EBV) was studied in primary human mononuclear leukocytes. When the leukocytes were exposed to EBV (strain B95-8 or P3HR-1) the IFN level reached a maximum 24 h after exposure to the virus, and a gradual decrease followed. A linear relationship was obtained between the input dose of EBV and the IFN titre. The IFN inducibility of leukocytes did not correlate with the EBV infectibility. IFN was also induced by u.v.-inactivated EBV and heat-inactivated EBV, but not by neutralized virus. IFN inducibility varied among adult donors, but there was no significant difference between EBV-seropositive and -seronegative groups. The response of cord blood leukocytes, however, was lower than that of the cells from adults. The activity of all IFN samples in this study was stable to acid and heat and exclusively neutralized by anti-human IFN-cc. B cells, T cells and NK cells all produced IFN in response to EBV, but monocytes did not.
The ubiquitous Epstein-Barr virus (EBV) can readily convert in vitro normal human lymphocytes to blast cells which have an infinite replicative capacity. EBV is also causally associated with certain clinical diseases, such as self-limited infectious mononucleosis and also Burkitt's lymphoma and nasopharyngeal carcinoma (for review, see Epstein & Achong, 1979) . Interferon (IFN) appears to play an important role in suppressing infection and transformation by EBV (Adams et al., 1975a; Menezes et al., 1976; Lai et al., 1977; Aya et al., 1980; ThorleyLawson, 1981 ; Lvovsky et al., 1981 ; Doetsch et al., 1981 ; Biron et al., 1981 ; Slovin et al., !983) . In the present study on IFN production by EBV in primary human mononuclear leukocytes, we found that both transforming and non-transforming strains of EBV are capable of inducing exclusively IFN-~ in both EBV-seropositive and -seronegative donor leukocytes. The cells producing IFN were found in all fractions: B cells, T cells and NK cells.
Sixteen EBV-seropositive and four EBV-seronegative healthy adults, and 12 cord blood samples were the subjects of study. Mononuclear leukocytes obtained from heparinized blood by centrifugation on Isopaque-Ficoll gradients were exposed to dextran gradient-purified (Dolyniuk et al., 1976) EBV strain B95-8 (Miller & Lipman, 1973) or EBV strain P3HR-1 (Hinuma et al., 1967) at various m.o.i.s at 37 °C for 90 min. The dose of EBV inoculum was expressed as the number of EBV DNA molecules, as determined by DNA-DNA reassociation kinetics (Nonoyama & Pagano, 1973) . The cells were then incubated in RPMI 1640 medium supplemented with 209/o heat-inactivated foetal calf serum and 10% tryptose phosphate broth. For IFN assay, the infected culture fluids were tested in a semi-micro, dye-binding assay (Armstrong, 1971) , based on the inhibition of the c.p.e, of vesicular stomatitis virus (VSV) in human amnion FL cells. The IFN titre of the sample was corrected with the NIH human leukocyte reference standard 69/19 and was expressed as international units (IU)/ml and IU/cell. IFN Characterization was made by neutralization, using rabbit antisera specific for 0022-1317/84/0000-5917 $02.00©1984 SGM t Expressed as maximum values of EBNA synthesis preceding cellular DNA induction, at 24 h after EBV exposure (Takada & Osato, 1982) .
IFN-~ (160 000 U/ml), IFN-fl (5000 U/ml) and IFN-y (30 000 U/ml), respectively. After incubation of serially diluted IFN samples with appropriately diluted antisera at 37 °C for 1 h, the mixtures were assayed for residual IFN activity. Acidification was carried out by dialysis against pH 2.0 glycine buffer for 2 days and the heat stability oflFN samples was tested at 56 °C for 30 min. Table 1 summarizes the data on IFN production of individual mononuclear leukocyte preparations after infection with B95-8 EBV. When 3 x 106 cells were infected with EBV at an m.o.i, of 100 EBV DNA copies/cell and the culture fluids were harvested at 24 h after viral exposure, at which time the IFN production had reached a maximum, all but one of the seropositive donors responded significantly to EBV. The IFN levels varied among the donors (range < 4 to 406 IU/ml) and the average value was 116 IU/ml (3.9 x 10-5 IU/cell). No significant correlation was noted between IFN and EBV antibody titres (data not shown). IFN was also induced in all of the seronegative donors tested, with an average value of 100 IU/ml (3.3 x 10-s IU/cell) (range 55 to 163 IU/ml). In contrast, IFN production by cord blood leukocytes was significantly lower than those in the seropositive and seronegative adult groups (P < 0.001). Three of the 12 cord samples did not produce significant amounts of IFN and the average value was 12 IU/ml (4-0 x 10 -6 IU/celI) (range < 4 to 21 IU/ml). There was no correlation between nuclear antigen (EBNA) (Reedman & Klein, 1973) inducibility and IFN inducibility by EBV. The differences between individuals in IFN production were consistent in three separate experiments. IFN production also varied among donors in response to EBV strain P3HR-1 (data not shown).
Further characterization of IFN production by EBV was carried out in an EBV-seropositive, high IFN producer healthy adult (donor SP-2). As shown in Fig. 1, IFN 5 and 7, followed by incubation with fresh medium each time, the IFN titres obtained were 96, 65 and below 4 IU/ml (3.2 x 10 -5, 2.2 × 10 -5 and < 1.3 x 10 -6 IU/cell), respectively. Essentially the same kinetics of IFN production were obtained when using u.v.-or heatinactivated EBV strain B95-8. EBV strain P3HR-1 also induced IFN production similarly, although with slightly lower titres (data not shown). IFN was not induced by neutralized virus, and no significant IFN induction was noted in uninfected mononuclear leukocytes throughout the incubation period.
The IFN production in response to EBV was then studied as a function of input virus dose, as illustrated in Fig. 2 . When mononuclear leukocytes were exposed to various dilutions of EBV strain B95-8 and IFN production was examined at 24 h, at which time the IFN activity reached a maximum, a linear relationship was obtained between EBV concentration and the titre of IFN. Increasing IFN levels of 244, 610 and 915 IU/ml (8.1 x 10 -5, 2.0 x 10 -4 and 3.1 x 10 -4 IU/cell) were evident by exposure to 10, 100 and 1000 EBV DNA copies/cell, respectively. IFN was also induced in response to EBV strain P3HR-1 also with a linear relationship, although the titres were twofold lower than with EBV strain B95-8. IFN induction was also directly proportional to the dilution of u.v.-or heat-inactivated EBV (data not shown).
In order to determine the type of IFN induced in this study, the culture fluids of mononuclear leukocytes from the seropositive adults, the seronegative adults, and the cord blood samples collected on days 1, 3, 5 and 7 after exposure to infectious, u.v.-irradiated or heat-treated EBV strain B95-8, respectively, were exposed to a low pH of 2.0 or a high temperature of 56 °C. All IFN activities were stable (0K loss) under these conditions. It was further shown that all IFN samples were exclusively neutralized by anti-HulFN-ct (98 % loss of activity), but not by anti-IFN-fl (0~o loss) and anti-IFN-7 (0K loss). Culture fluids obtained differentially after washing on days 1, 3, 5 and 7 also contained ony IFN-~. The results were also the same with IFN induced by EBV strain P3HR-1 (data not shown). Short communication * Cell fractionation was carried out as follows. Monocytes were collected from whole mononuclear leukocytes through adherence on plastic dishes coated with foetal calf serum. Monocyte-depleted lymphocytes were obtained by silica phagocytosis. A monocyte-depleted, NK cell-depleted fraction was then obtained by cytolysis with anti-NK serum and complement. A B cell fraction was purified from the monocyte-depleted, NK cell-depleted fraction by elimination of T ceils through E-rosette formation and cytolysis with auti-T serum and complement. T cells were purified from the monocyte-depleted, NK cell-depleted fraction through E-rosetting and cytolysis with anti-B serum and complement. 3 x 106 cells of each fraction were exposed to B95-8 EBV (100 EBV DNA copies/cell) and IFN activity of the infected culture fluid was measured in a semi-micro, dye-binding assay 24 h after EBV exposure. Triplicate cultures were used.
"~ Treatment of IFN samples with anti-IFN was carried out as described in the text. :~ ND, Not done.
It was also of interest to determine which cell type was producing IFN within the primary mononuclear leukocytes. As summarized in Table 2 , fractions of B cells, T cells and NK cells all produced IFN-ct exclusively in response to EBV. IFN was not significantly induced in monocytes; indeed, its production was rather inhibited by their presence in mononuclear leukocytes.
Reports have previously described induction by EBV of factors suppressing EBV infection and transformation of primary mononuclear leukocytes (Lai et al., 1977; Thorley-Lawson, 1981) . However, the nature of the factors was not as well characterized as IFN. Our findings show that purified EBV preparations can induce IFN-~ exclusively in not only EBV-susceptible B cells but also in non-susceptible T and NK cells, regardless of the infecting EBV strain, the input virus dose, the time after EBV exposure, the virus infectivity and the EBV-specific immune status of leukocyte donors. Since no significant correlation was noted between EBV infectibility and IFN inducibility of leukocytes, more IFN was induced by exposure to more u.v.-inactivated EBV and heat-inactivated EBV, but not by neutralized virus, and since IFN was induced in all B, T and NK cells, IFN production was probably generated by non-specific contact of EBV with the surface of mononuclear leukocytes in a dose-dependent fashion.
Although IFN inducibility by EBV of primary mononuclear leukocytes varies among individuals, all but one of the 20 adult donors tested, not only EBV-seropositive but also -seronegative, produced IFN. IFN was released rapidly and the activity reached a maximum as early as 24 h after EBV exposure. Such IFN production was calculated as 10 -4 to 10 -5 IU/cell, an amount which is significantly higher than the 10-5 to 10-6 IU/cell from established B cell lines (Swart & Young, 1969; Zajac et al., 1969; Adams et al., 1975b) .
HLA-restricted killing of EBV-transformed B lymphocytes by primed T cells is known to be the major mechanism for restricting proliferation of the transformed cells (Rickinson et al., 1980) . EBV infection and transformation can also be effectively suppressed by the direct action of IFN and by IFN-mediated activation of NK, T and K cells (Adams et al., 1975 a; Menezes et al., 1976; Aya et al., 1980; Thorley-Lawson, 1981 ; Lvovsky et al., 198"1 ; Doetsch et al., 1981 ; Biron et al., 198l ; Slovin et al., 1983) . In this respect, IFN production by primary mononuclear leukocytes in quick response to a large dose of EBV, as shown in this study, might be significant in young adults preventing the occurrence of infectious mononucleosis through early elimination of numbers of cells freshly infected and transformed by EBV, although some Burkitt's lymphoma cell lines are resistant to IFN (Adams et al., 1975 a) . In contrast to adults, cord blood
